The store will not work correctly when cookies are disabled.
3-{[4-(3,4-Dichlorophenyl)piperazin-1-yl]methyl}-2,5,7-trimethylimidazo[1,2-c]pyrimidine
ID: ALA563078
PubChem CID: 45273442
Max Phase: Preclinical
Molecular Formula: C20H23Cl2N5
Molecular Weight: 404.35
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)n2c(C)n1
Standard InChI: InChI=1S/C20H23Cl2N5/c1-13-10-20-24-14(2)19(27(20)15(3)23-13)12-25-6-8-26(9-7-25)16-4-5-17(21)18(22)11-16/h4-5,10-11H,6-9,12H2,1-3H3
Standard InChI Key: OPCWNMLUZVXULW-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
12.7562 -0.6737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7562 -1.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0417 -1.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0417 -0.2612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3272 -0.6737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.3272 -1.4987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5426 -1.7537 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0577 -1.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5426 -0.4188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2327 -1.0862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2877 0.3658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4807 0.5374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2258 1.3220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4188 1.4935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8668 0.8804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1217 0.0958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9287 -0.0757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0598 1.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5078 0.4388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7008 0.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4459 1.3950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9979 2.0081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8049 1.8366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4707 -1.9112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0417 0.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6389 1.5665 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.7430 2.7927 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3 6 1 0
1 2 1 0
5 4 1 0
6 7 2 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
7 8 1 0
8 9 2 0
18 19 2 0
9 5 1 0
19 20 1 0
4 1 2 0
20 21 2 0
8 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 18 1 0
15 18 1 0
9 11 1 0
2 24 1 0
4 25 1 0
11 12 1 0
12 13 1 0
21 26 1 0
2 3 2 0
22 27 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.35 | Molecular Weight (Monoisotopic): 403.1331 | AlogP: 4.28 | #Rotatable Bonds: 3 |
Polar Surface Area: 36.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.90 | CX LogP: 2.75 | CX LogD: 2.63 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.65 | Np Likeness Score: -1.95 |
References
1. Linz S, Müller J, Hübner H, Gmeiner P, Troschütz R.. (2009) Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases., 17 (13): [PMID:19481941] [10.1016/j.bmc.2009.05.015] |